शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
TRIGYNNSETrigyn Technologies Limited· IT - SoftwareHighNegative
Announced Tue, 10 Mar, 2026 · 24:28 IST

Trigyn Technologies Limited has informed the Exchange regarding Resignation of Mr Dr. Satyam Cherukuri as Chairman & Non Executive Director of the company w.e.f. April 07, 2026.

TRIGYN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.2%Reaction day
₹49.00
prior close
₹48.04
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+2.4%-3.6% vs market
Computers - Software & Consulting peers, median of 69sector+1.5%-2.7% vs sector

On the reaction day the stock moved 3.6 pts less than Nifty Microcap 250 and 2.7 pts less than its Computers - Software & Consulting peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+2.0
10m
+2.2
15m
+2.4
30m
+2.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.2+2.4-3.6+1.5-2.7
Next day
-2.3+2.3-4.6+1.6-4.0
2d
-0.9+2.0-2.9+0.4-1.3
3d
-3.5-1.0-2.5-2.2-1.3
4d
-5.2-1.6-3.6-2.6-2.6
5d
-5.3-0.6-4.7-3.0-2.3
1w
-2.0-0.8-1.2-4.5+2.5
15d
-8.4-0.1-8.3-1.9-6.6
1m
+10.0+7.7+2.3+3.6+6.4
2m
+21.3+18.8+2.5+6.3+15.0
3m
+12.8+18.1-5.3+3.0+9.8
UpDownMarket · Nifty Microcap 250Sector · Computers - Software & Consulting peers, median of 69Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Satyam Cherukuri (DIN: 01294234) has resigned as Chairman and Non-Executive Director of Trigyn Technologies Limited, with effect from April 7, 2026. He is stepping down because personal circumstances now require his full attention, according to the disclosure filed under SEBI's listing regulations. He is also exiting the board of the company's US subsidiary, Trigyn Technologies Inc., on the same date. The company has appreciated his contributions during his tenure and noted that he has committed to a smooth transition, including being available to brief his successor. The resignation letter has been enclosed and filed with the exchanges.

Likely market impact

This is a senior board-level exit, but since Dr. Cherukuri held a non-executive role, day-to-day operations are unlikely to be disrupted. The reason is personal rather than performance or governance-related, which is reassuring. Shareholders should watch for an announcement regarding his successor on the board.